HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of fexofenadine hydrochloride in a guinea pig model of antigen-induced rhinitis.

Abstract
Allergic rhinitis is an inflammatory disease of the nasal mucosa, induced by histamine, leukotrienes, and other substances released from mast cells. Fexofenadine hydrochloride, the active metabolite of terfenadine, is a novel, nonsedating antiallergic drug having H1 receptor antagonistic activity. Fexofenadine is effective for the treatment of allergic rhinitis. However, its mechanism of action in attenuating nasal congestion has not yet been elucidated. Therefore, we first examined the effects of fexofenadine on a guinea pig model of antigen-induced rhinitis. We also evaluated the effects of mepyramine, zafirlukast and ramatroban in this model; these drugs are an H1 receptor antagonist, a selective leukotriene antagonist and a selective thromboxane antagonist, respectively. Rhinitis was induced by ovalbumin (OVA) instillation into the nasal cavity of animals that had been sensitized by two earlier OVA injections (s.c. and i.p.). The nasal airway resistance was measured for 45 min after the challenge. Fexofenadine hydrochloride (20 mg/kg) and terfenadine (20 mg/kg) administered orally 70 min prior to the challenge significantly inhibited (fexofenadine, p < 0.001, terfenadine, p < 0.05) the increase in nasal airway resistance. Ramatroban (30 mg/kg) administered orally 60 min prior to the challenge also significantly inhibited (p < 0.05) the increase in nasal airway resistance. In contrast, mepyramine (3 mg/kg i.v.) and zafirlukast (3 mg/kg p.o.) failed to reduce the increase in nasal airway resistance. These results suggest that thromboxane may be involved in the increase in the nasal airway resistance in this model. Accordingly, fexofenadine may reduce the increase in nasal airway resistance by inhibiting the release of chemical mediators, including thromboxane, that are involved in the increase in nasal airway resistance in this model.
AuthorsTakashi Sakairi, Katsuhisa Suzuki, Shigeki Makita, Teruaki Wajima, Shuji Shakuto, Yasushi Yoshida, Masafumi Yaguchi
JournalPharmacology (Pharmacology) Vol. 75 Issue 2 Pg. 76-86 (Oct 2005) ISSN: 0031-7012 [Print] Switzerland
PMID16037679 (Publication Type: Journal Article)
CopyrightCopyright 2005 S. Karger AG, Basel.
Chemical References
  • Anti-Allergic Agents
  • Carbazoles
  • Indoles
  • Leukotrienes
  • Phenylcarbamates
  • Sulfonamides
  • Thromboxanes
  • Tosyl Compounds
  • Terfenadine
  • Ovalbumin
  • fexofenadine
  • Pyrilamine
  • ramatroban
  • zafirlukast
Topics
  • Airway Resistance (drug effects)
  • Animals
  • Anti-Allergic Agents (pharmacology)
  • Area Under Curve
  • Carbazoles (pharmacology)
  • Disease Models, Animal
  • Guinea Pigs
  • Indoles
  • Leukotrienes (physiology)
  • Male
  • Ovalbumin (immunology)
  • Phenylcarbamates
  • Pyrilamine (pharmacology)
  • Rhinitis (drug therapy)
  • Sulfonamides (pharmacology)
  • Terfenadine (analogs & derivatives, pharmacology, therapeutic use)
  • Thromboxanes (physiology)
  • Tosyl Compounds (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: